Internal Medicine, Infectious Disease · Atlanta, GA
NPI
1144635160
Since 2014
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
303 Parkway Dr NE
Atlanta, GA, 30312
Phone (404) 265-4919
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
2,809 services
Medicare patients, 2024
448
Average age 76
Drug cost, 2024
$473K
779 prescriptions
Company payments, 2025
$1,423
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zohra S Chaudhry was code 99232 (hospital e&m - subsequent), 2,037 times for 364 patients. In total Zohra S Chaudhry billed 2,809 services in 16 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,037 | 364 | $56.09 | $114K |
| 99223 Hospital E&M - Initial | Facility | 329 | 275 | $124.09 | $41K |
| 99214 Office E&M - Established | Office | 165 | 92 | $88.49 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 100 | 48 | $12.09 | $1,209 |
| 99233 Hospital E&M - Subsequent | Facility | 82 | 66 | $86.34 | $7,080 |
| 99213 Office E&M - Established | Office | 32 | 27 | $63.44 | $2,030 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 30 | 28 | $170.95 | $5,129 |
| 99204 Office E&M - New | Office | 15 | 15 | $120.49 | $1,807 |
By year: 2022 $153K for 2,251 services; 2023 $145K for 2,010 services; 2024 $189K for 2,809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zohra S Chaudhry prescribed most often to Medicare patients was Daptomycin, with 181 prescriptions and refills. In total Zohra S Chaudhry wrote 779 Medicare prescriptions that cost $473K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 181 | 181 | 39 | $68K |
| Cefepime Hcl Generic | 56 | 56 | 14 | $12K |
| Ertapenem Ertapenem Sodium | 48 | 48 | Under 11 | $20K |
| Sodium Chloride 0.9 % Sodium Chloride | 48 | 48 | Under 11 | $258 |
| Ceftriaxone Ceftriaxone Sodium | 47 | 47 | 13 | $5,574 |
| Fluconazole Generic | 40 | 40 | 20 | $1,695 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 36 | 36 | Under 11 | $4,905 |
| Cephalexin Generic | 22 | 22 | 11 | $195 |
| Doxycycline Hyclate Generic | 21 | 23 | 14 | $397 |
| Linezolid Generic | 17 | 19 | 14 | $2,825 |
| Cefazolin Sodium Generic | 16 | 16 | Under 11 | $787 |
| Aztreonam Generic | 15 | 15 | Under 11 | $8,601 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 14 | 14 | Under 11 | $62K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 15 | Under 11 | $66.36 |
| Vancomycin Hcl Generic | 12 | 12 | Under 11 | $265 |
Brand drugs: 166 claims; generic drugs: 613 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zohra S Chaudhry $1,423 ($1,423 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $324.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $324 |
| Cumberland Pharmaceuticals, Inc. CPIX | 14 | $264 |
| Merck Sharp & Dohme LLC MRK | 9 | $215 |
| Insmed, Inc. INSM | 13 | $213 |
| Melinta Therapeutics, LLC | 4 | $84.46 |
| Theratechnologies Inc. THTX | 4 | $81.96 |
| Aimmune Therapeutics, Inc. | 3 | $61.32 |
| Paratek Pharmaceuticals, Inc. | 2 | $45.9 |
| ViiV Healthcare Company GSK | 2 | $45.26 |
| Astellas Pharma US Inc 4503.T | 2 | $43.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.